Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA.
However, the lack of oxygen in the center of tumors blocks the production of free radicals, inhibiting radiation killing.
NIBIB researchers have now designed a nanoparticle that generates radiation-induced oxygen free radicals even in the low-oxygen center of tumors, dramatically increasing the success of radiation therapy.
Low oxygen (hypoxic) regions in the core of tumors results in strong resistance to radiation therapy causing cancer invasion and metastasis.
Hypoxia, a common feature of solid tumors, occurs in the core region of most cancers, so developing therapies that overcome the tumor hypoxia problem is a critical goal for increasing the effectiveness of cancer therapy.
In the NIBIB Laboratory of Molecular Imaging and Nanomedicine (LOMIN), headed by Xiaoyuan (Shawn) Chen, Ph.D., Senior Investigator, one of the main areas of research is the creation of nanoparticles that can target and kill tumors without harming surrounding healthy tissues.
Towards that end the lab has created various nanoparticles, many that carry chemotherapy drugs such as doxorubicin, and release it at the tumor site.
In the current study spearheaded by Wenpei Fan, Ph.D., a postdoctoral fellow in the LOMIN laboratory, the nanoparticle is carrying a different class of molecules – compounds designed to work with radiation and enhance its ability to kill tumor cells. The work is reported in the March edition of the journal Nature Communications.
Completing the nanoparticle. The hollow nanoparticle is coated with a compound called PEG (blue lines) that helps it dissolve when injected into the bloodstream.
The particle is then loaded with the compounds (red and white balls) that are activated by radiation to create tumor-killing oxygen free radicals. Credit: Adapted from Fan, et al. Nat Comm, March-2019
The nanoparticle that they engineered is called a hollow mesoporous organosilica nanoparticle (HMON).
Mesoporous refers to the size of the pores in the nanoparticle, through which anti-cancer compounds can be loaded and then released when they reach the tumor.
A mesoporous material contains pores with a diameter between 2 and 50 nanometers.
For comparison, microporous materials have pores smaller than 2 nanometers.
Organosilica refers to the basic structure, which is silica, a material like quartz. Specific organic molecules are added to the organosilica mix to create nanoparticles with the desired pore size for loading the anti-cancer compounds.
The researchers used a special technique called ammonia-assisted hot water etching to engineer very small nanoparticles.
Creating very small nanoparticles was important because the smaller particles could travel to the center of the tumor, which was the primary goal of these experiments.
The small particles were made by starting out with a very small central bead that was basically the mold for the nanoparticle shell that was bound to the outside of the bead.
However, the nanoparticles must be hollow to carry their cancer-killing payload.
This is where the ammonia-assisted hot water etching came in.
This particular method was used because it etches away or degrades the central bead but does not damage the outer coating.
In this way the central bead was etched away leaving the very small hollow mesoporous nanoparticle.
Mechanism of action. When hit with radiation the particle produces destructive oxygen free radicals in normal and low oxygen parts of the tumor. Carbon monoxide gas (CO), which is toxic to tumors is further created when the oxygen free radicals interact with the compound FeCO resulting in radio-dynamic RDT/gas therapy. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB
The nanoparticles were then loaded with two different compounds.
One compound creates oxygen free radicals in an oxygen rich environment of a tumor when hit with radiation, which is the outer portions of the tumor.
The other compound is able to create oxygen free radicals when hit with radiation in the hypoxic core of the tumor.
The oxygen free radicals are very reactive, and they damage the tumor cell DNA, killing the cancer cells.
The loaded nanoparticles were tested in a human glioblastoma cell line for the amount of DNA damage that was generated when combined with radiation.
A test that dyes the DNA fluorescent red clearly showed that the combination of the nanoparticles and radiation shredded the DNA of the glioblastoma cells compared with nanoparticles alone or radiation alone.
Additional tests demonstrated that the nanoparticles generated oxygen free radicals when exposed to radiation in both normal and very low oxygen conditions, confirming that the system worked as designed.
The cancer cell killing of the HMONs was further enhanced by the fact that the two compounds loaded into the nanoparticles react with each other upon radiation.
The result is the production of carbon monoxide gas, which is toxic to the cancer cells.
The combination of the oxygen free radical killing and the carbon monoxide killing upon radiation resulted in what the researchers termed radio-dynamic therapy or RDT/gas therapy.
The RDT/gas therapy was tested in tumors in mice.
When the nanoparticle was injected into the bloodstream of the mice without radiation there was only a minimal effect on the tumors.
Radiation alone also had a minimal effect.
However, when the nanoparticle was injected and then activated by radiation, the tumors shrank dramatically with no toxic effects on the organs of the mouse.
Says the lead author Fan, “We believe this RDT/gas therapy approach offers new possibilities for enhanced X-ray-activated treatment for future deep-cancer therapy.
The next logical step is to optimize the structure and scale up nanoparticle synthesis to allow clinical translation of this type of radiotherapy enhancement.”
More information: Wenpei Fan et al. Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy, Nature Communications (2019). DOI: 10.1038/s41467-019-09158-1
Journal information: Nature Communications
Provided by National Institutes of Health